Figure 4.
Impaired desensitization of truncated CXCR4m receptors. (A) CXCL12-triggered actin polymerization in CD8+-gated (left panels) and CD4+-gated (right panels) T cells from WHIM1013 patients P1 (top row, •) and P2 (bottom row, •) or from healthy donors (□). (B) Kinetics of CXCL12-triggered actin polymerization in A0.01 T cells (left panel) or in CD4+-gated T lymphocytes (right panel) nontransduced (NT) or transduced with the indicated CXCR4 variants (▵, CXCR4wt; ▦, CXCR41000; •, CXCR41013; □, NT). (A-B) Data are representative of 3 independent experiments. (C) GTPγS binding assays to membranes from HEK-293T cells expressing at similar levels CXCR4wt (left panel, ○; right panel, □), CXCR41000 (left panel, ; right panel, ▦), or CXCR41013 (▪) (geometric MFI for the aforementioned receptors were 11.2, 12.3, and 10.5, respectively). Membranes were treated with the indicated concentrations of CXCL12 (left panel) or left untreated (right panel). Data are mean ± SEM of triplicate determinations. Deduced EC50 values of the experiment of 3 independent determinations were 17 nM for CXCR4wt, 7 nM for CXCR41000, and 9 nM for CXCR41013.